Hypertension, coronary risk and alpha-blockade.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D003327:Coronary Disease / Q000453:epidemiology*; D017292:Doxazosin; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011224:Prazosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012307:Risk Factors
D000317:Adrenergic alpha-Antagonists; D017292:Doxazosin; D011224:Prazosin